Drawing for W

USPTO serial 79149169

W

Reviewed by CopyMark Law Group

Reg. 4745671Status 404
Filing date
Status date
Registration date
Jun 2, 2015
Examiner
WIENER, MICHAEL
Law office
POST REGISTRATION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with W?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark Lebow

1727 King StreetSuite 105Alexandria, VA 22314

Goods and services

ClassDescriptionStatusFirst use
009Software, namely, software for providing information on pricing and reimbursement assessments in health economic and market access strategies and plans in the health care industrySECTION 71 - CANCELLED
035Advertising; commercial business management, and marketing and professional business consultancy; advertising products of third parties in the health care industry; business management, namely, marketing and professional consultation in pricing and reimbursement strategies for brands and products at all stages of lifecycle development; brand management for businesses; brand management for pharmaceutical and medical device companies; business management and consultation providing commercial and clinical commercial strategies and commercial strategies for the production of integrated evidence plans to support pricing, reimbursement and market access; commercial business management, namely, development of value strategies for internal communication with cross-functional teams and senior management of companies to facilitate internal decision making; commercial business management, namely, development of early pricing and reimbursement strategies for brands, product management consulting at all development stages, and licensing opportunities; commercial business management, namely, conducting of pricing and reimbursement landscape assessments; commercial business management, namely, conducting of competitor analyses and development of pathways for disease management for comparative effectiveness research planning; commercial business management, namely, development of payer objection handler documents identifying potential payer objections to product reimbursement and arguments to address them; preparation of briefing documents for payer advisory boards; commercial business management, namely, conducting qualitative small scale payer research for hypothesis generation and unbranded or branded payer message testing and validation; commercial business management, namely, providing placement for market access managers and directors; commercial business management, namely, development of health economics and outcomes research strategies to support internal communication with cross-functional teams and senior management to facilitate internal strategic decisions; commercial business management, namely, providing strategic support for the development of economic models; design and development of budget impact models; commercial business management, namely, development of actionable plans to support the value communication of a product; commercial business management, namely, planning, preparation, coordination and conducting of expert panels and advisory boards; planning and conducting of database-registry analysesSECTION 71 - CANCELLED
041Education and training services, namely, workshops and seminars in the field of branding, product valuation and pricing, healthcare, and economics; education and training services, namely, workshops and seminars in the field of design and facilitation of product value and strategy; workshops and seminars in the field of design and facilitation of product value; workshops and seminars in the field of economic strategies and support of health economic deliverables; workshops and seminars in the nature of training to instruct on planning, preparation, coordination and conducting of expert panels and advisory boards for presentations and briefing documents in the health care industry; training services in the field of facilitation of workshops with cross-functional teams and affiliates to develop and refine economic strategies and support the adaptation of health economic deliverables; and workshops and seminars in the field of cross-functional and regional applied health economics trainingSECTION 71 - CANCELLED
042Scientific and technological services and research and design services relating thereto, namely, scientific and technological competitor analysis and developing pathways for disease management for competitive research planning, conducting qualitative payer research for hypothesis, testing and validation; * all the aforesaid services not provided in the field of energy transport, production and/or exploration; * design and development of computers and software; design and development of computers and software for third parties * ; excluding software in connection with energy transport, production and/or exploration *SECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 8, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 8, 2024DETHDEATH OF INTERNATIONAL REGISTRATION
Oct 24, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB
Sep 25, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 24, 2022INPCINVALIDATION PROCESSED
Aug 17, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 17, 2021C71TCANCELLED SECTION 71
Jun 2, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 26, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED
Oct 30, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Oct 30, 2015COC.CORRECTION UNDER SECTION 7 - PROCESSED
Oct 30, 2015LIMELIMITATION FROM THE IB EXAMINED AND ENTERED
Sep 25, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 25, 2015FIMPFINAL DISPOSITION PROCESSED
Sep 24, 2015LIMGLIMITATION OF GOODS RECEIVED FROM IB
Sep 2, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 2, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 17, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 25, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 10, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 9, 2015ALIEASSIGNED TO LIE
Jan 23, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 23, 2015XAECEXAMINER'S AMENDMENT ENTERED
Jan 23, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 23, 2015GNEAEXAMINERS AMENDMENT E-MAILED
Jan 23, 2015CNEAEXAMINERS AMENDMENT -WRITTEN
Oct 20, 2014GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Oct 20, 2014GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 20, 2014CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 30, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 22, 2014RFNTREFUSAL PROCESSED BY IB
Aug 5, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 5, 2014RFRRREFUSAL PROCESSED BY MPU
Aug 5, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 4, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 2, 2014MAFRAPPLICATION FILING RECEIPT MAILED
Jul 29, 2014DOCKASSIGNED TO EXAMINER
Jul 29, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 21, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance